Rapid Micro BiosystemsRPID
RPID logo
Fair Value
US$5
Share price13 Jun
US$2.0658.8% undervalued intrinsic discount
Loading
1Y-39.59%
7D0.49%

Slow Automation Adoption And Partner Execution Risks May Eventually Support QC Automation Upside

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
13 Jun 26
Views
2
Not Invested

Fair Value vs Share Price

US$5
vs US$2.0658.8% undervalued intrinsic discount
PastFuture-68m70m2019202120232025202620272029Revenue US$70.0mEarnings US$10.9m
26.7%
Revenue growth
15.6%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Rapid Micro Biosystems

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and slightly overvalued.

Market capUS$103.3m
PB5.0x
Estimated Growth19.7%
Dividend YieldN/A
Full analysis

CEO & management

Robert Spignesi
CEO
4.7yrs
CEO Tenure

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.